This Might Be The Future of Hodgkin Lymphoma Treatment
At first, Adcetris was a last resort
Adcetris has actually been around since 2011. It was only used them for people who had Hodgkin's for the second time after already getting a stem cell transplant or at least two other chemotherapy cocktails. It was really a last resort type of medication back then. But the miracles doctors witnessed in relapse patients using this drug drew attention. When there was a bleomycin shortage in 2016, doctors at Stanford started to use Adcetris for their advanced stage patients.
